NextPlat Corp Quarterly report pursuant to Section 13 or 15(d)

Note 18 - Reportable Segments (Tables)

9 Months Ended

Sep. 30, 2024

For the Three Months Ended September 30, 2024	*e-Commerce Operations*			*Healthcare Operations*			*Eliminations*			*Total*
Pharmacy prescription and other revenue, net of PBM fees	$	—		$	9,076		$	—		$	9,076
e-Commerce revenue		3,834			—			—			3,834
Pharmacy 340B contract revenue		—			2,457			—			2,457
Revenues, net	$	3,834		$	11,533		$	—		$	15,367

Expenses:
Cost of revenue		2,756			9,091			—			11,847
Selling, general and administrative		969			1,384			(60	)		2,293
Salaries, wages and payroll taxes		617			2,258			—			2,875
Impairment loss		—			3,729			—			3,729
Professional fees		1,481			663			—			2,144
Depreciation and amortization		141			337			—			478
Total expenses		5,964			17,462			(60	)		23,366
Loss before other (income) expense		(2,130	)		(5,929	)		60			(7,999	)
Other income		(324	)		(116	)		60			(380	)
Loss before income taxes		(1,806	)		(5,813	)		—			(7,619	)
Income taxes		(45	)		—			—			(45	)
Net loss	$	(1,851	)	$	(5,813	)	$	—		$	(7,664	)

For the Three Months Ended September 30, 2023	*e-Commerce Operations*			*Healthcare Operations*			*Eliminations*			*Total*
Pharmacy prescription and other revenue, net of PBM fees	$	—		$	9,888		$	—		$	9,888
e-Commerce revenue		2,931			—			—			2,931
Pharmacy 340B contract revenue		—			2,471			—			2,471
Revenues, net	$	2,931		$	12,359		$	—		$	15,290

Expenses:
Cost of revenue		2,127			8,578			—			10,705
Selling, general and administrative		1,978			2,269			(60	)		4,187
Salaries, wages and payroll taxes		564			1,919			—			2,483
Professional fees		278			243			—			521
Depreciation and amortization		164			707			—			871
Total expenses		5,111			13,716			(60	)		18,767
Loss before other (income) expense		(2,180	)		(1,357	)		60			(3,477	)
Other (income) expense		(76	)		17			60			1
Loss before income taxes		(2,104	)		(1,374	)		—			(3,478	)
Income taxes		(23	)		—			—			(23	)
Loss before equity method investment		(2,127	)		(1,374	)		—			(3,501	)
Gain on equity method investment		6,138			—			—			6,138
Equity in net loss of affiliate		—			—			—			—
Net loss	$	4,011		$	(1,374	)	$	—		$	2,637

For the Nine Months Ended September 30, 2024	*e-Commerce Operations*			*Healthcare Operations*			*Eliminations*			*Total*
Pharmacy prescription and other revenue, net of PBM fees	$	—		$	30,922		$	—		$	30,922
e-Commerce revenue		10,210			—			—			10,210
Pharmacy 340B contract revenue		—			8,717			—			8,717
Revenues, net	$	10,210		$	39,639		$	—		$	49,849

Expenses:
Cost of revenue		7,217			28,496			—			35,713
Selling, general and administrative		3,517			3,179			(180	)		6,516
Salaries, wages and payroll taxes		1,744			6,540			—			8,284
Impairment loss		—			13,653			—			13,653
Professional fees		2,608			1,525			—			4,133
Depreciation and amortization		417			1,870			—			2,287
Total expenses		15,503			55,263			(180	)		70,586
Loss before other (income) expense		(5,293	)		(15,624	)		180			(20,737	)
Other income		(735	)		(166	)		180			(721	)
Loss before income taxes		(4,558	)		(15,458	)		—			(20,016	)
Income taxes		(92	)		—			—			(92	)
Net loss	$	(4,650	)	$	(15,458	)	$	—		$	(20,108	)

For the Nine Months Ended September 30, 2023	*e-Commerce Operations*			*Healthcare Operations*			*Eliminations*			*Total*
Pharmacy prescription and other revenue, net of PBM fees	$	—		$	9,888		$	—		$	9,888
e-Commerce revenue		8,764			—			—			8,764
Pharmacy 340B contract revenue		—			2,471			—			2,471
Revenues, net	$	8,764		$	12,359		$	—		$	21,123

Expenses:
Cost of revenue		6,495			8,579			—			15,074
Selling, general and administrative		5,287			2,269			(60	)		7,496
Salaries, wages and payroll taxes		2,120			1,919			—			4,039
Professional fees		1,143			242			—			1,385
Depreciation and amortization		493			708			—			1,201
Total expenses		15,538			13,717			(60	)		29,195
Loss before other (income) expense		(6,774	)		(1,358	)		60			(8,072	)
Other (income) expense		(635	)		17			60			(558	)
Loss before income taxes		(6,139	)		(1,375	)		—			(7,514	)
Income taxes		(75	)		—			—			(75	)
Loss before equity method investment		(6,214	)		(1,375	)		—			(7,589	)
Gain on equity method investment		6,138			—			—			6,138
Equity in net loss of affiliate		(1,440	)		—			—			(1,440	)
Net loss	$	(1,516	)	$	(1,375	)	$	—		$	(2,891	)